Platelet Rich Plasma Market

Platelet Rich Plasma (PRP) Market: Adoption Growing in Orthopaedic and Cosmetic Surgery: Global Industry Analysis and Opportunity Assessment, 2016-2026

Ask The Analyst Customization Available Request Methodology

Overview:

Platelet rich plasma (PRP) is a blood plasma derived product, which typically consist of enriched platelets along with several growth factors, which ensure quick healing of bone as well as other soft tissues. Over last few years, preference as well as demand for platelet rich plasma based therapies have increased significantly. Injuries such as rotator cuff, hamstring, tendon injuries, tennis elbow necessitates PRP based therapy; and an increasing number of such injuries have been reported. In addition, number of orthopaedic surgeries, sports injuries and cosmetic surgeries also surged up, translating into the need for PRP based therapy viz.a.viz platelet rich plasma. Furthermore, use of PRP have also been established for diseases, where it was not used previously. Erectile dysfunction and facelift surgeries are some of few newly discovered area where PRPs can be used and potentially boost Platelet rich Plasma market growth during the forecast period. However, high cost of medical devices and PRP therapy are some of the factors restricting the market growth to some extent.

 PRP products are widely used in cosmetic surgeries to improve facial aesthetics, enhance the rate of injury healing and modify facial structure (vampire facelift treatment). In addition, cosmetic surgeries performed with the use of PRP products modify the facial aesthetics in a short period of time due to reduction in the healing time. Thus, cosmetic surgery application segment is likely to witness the impressive growth rate of over 14% during the forecast period from 2016 to 2026. Demand for PRP from cosmetic surgery application is estimated to surpass US$ 59 Mn by 2016, up from US$ 52.4 Mn in 2015, registering a Y-o-Y growth of 13.6% in 2016.

Platelet Rich Plasma Market by Application Outlook:

Cosmetic surgery is among the leading application segments of platelet rich plasma products. The application of PRP in cosmetic surgeries began in early 2000s with the purpose of meeting requirements for improving facial aesthetics. With the introduction of innovative cosmetology and PRP products, PRP therapy is being widely-adopted in various cosmetic surgeries. PRP products are widely used in cosmetic surgeries to improve facial aesthetics, enhance the rate of injury healing and modify facial structure (vampire facelift treatment). PRP products are also used as a substitute for dermal fillers such as hyaluronic acid. Hyaluronic acid is short-term dermal filler and hence, is being rapidly replaced by PRP products. PRP products show their results for a prolonged period (minimum for 18 months). The vampire facelift treatment using PRP products is an emerging application type in cosmetic surgery. It is a minimally-invasive and short-duration cosmetic surgery, which includes injections of PRP in the neck, hands, and the face to enhance aesthetic look. The cost of this treatment ranges approximately between US$ 600 and US$ 1,800, depending on the number of injections. Considering various benefits offered by PRP in cosmetic industry, it is extensively used in cosmetic surgery practices and this use is expected to increase in the near future. According to the statistics provided by the International Society of Plastic and Aesthetic Surgeons (ISAPS), 11 Mn non-invasive cosmetic procedures were performed worldwide in 2013, including approximately 3.0 Mn dermal filler procedures. This extensive number of cosmetic surgeries performed is considered as one of the most prominent factor propelling the growth of the global PRP market during the forecast period from 2015 to 2020.

platelet rich plasma market

Key Players:

Prominent players having presence in the global PRP market include Harvest Technologies Corp., Biomet, Inc., Arthrex, Inc. and Arteriocyte Medical Systems, Inc. Other players include Dr. PRP America, Cesca Therapeutics, Inc. and Regen Lab SA amongst others.

REPORT DESCRIPTION

Platelet rich plasma (PRP) is a blood plasma product in which concentration of platelets is elevated four to eight times higher than the normal blood platelet concentration. PRP is also called platelet rich gel, platelet enriched plasma and platelet enriched gels; and is used in effective treatment of various diseases such as orthopedic diseases, sports injuries, neurological diseases and cardiothoracic diseases. In addition, PRP therapy has an extensive application in cosmetic industry. This report studies the current scenario as well as future market potential for PRP globally.

The market overview section of the report comprises qualitative analysis of the overall PRP market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five force analysis and market attractiveness analysis. In addition, various analyses such as event impact analysis, regulatory scenario and value chain analysis has also been provided. Event impact analysis encompasses the major events occurred in past decade and are expected to occur during the forecast period and are likely to affect the market dynamics positively or negatively. Value chain analysis includes the study of major steps involved in the PRP devices preparation and distribution. Regulatory scenario includes the study of different regulatory norms and procedures that regulate the approval and commercialization of PRP devices and products. 

The global PRP market has been segmented on the basis of types, origins and applications. On the basis of types, the global PRP market is categorized as pure-PRP (P-PRP), leukocyte-rich PRP (L-PRP) and pure PRF/leukocyte-rich PRF (L-PRF). Moreover, on the basis of origin, the PRP market has been segmented into autologus, homologus and allogenic PRP. Furthermore, on the basis of applications, the global PRP market has been classified as neurosurgery, cosmetic surgery, orthopedic surgery, general surgery and others (cardiothoracic surgery, urology, periodontal surgery and oral and maxillofacial surgery). The market for these types, origins and applications has been extensively analyzed on the basis of factors such as usage pattern, sales revenue, geographic presence and technological developments. The market size and forecast in terms of revenue (US$ Mn) for each of these segments have been provided for the period 2012 to 2026, considering 2013 as the base year.

Geographically, the PRP market has been classified into four segments namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each region has been provided for the period 2012 to 2026, in terms of origin, types and applications, along with the CAGR (%) for the forecast period 2015 to 2026.

The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global PRP market, in terms of percentage share in 2013 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share. The report concludes with the profiles of major players in the global PRP market such as AdiStem Ltd., Arteriocyte Medical Systems, Inc., Arthrex, Inc., Biomet, Inc., Cesca Therapeutics, Inc., DePuy Synthes, Inc., Dr. PRP America LLC., EmCyte Corporation, Exactech, Inc., Harvest Technologies Corp., Nuo Therapeutics, Inc., Regen Lab SA, and Stryker Corporation. The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies and recent developments.

Global Platelet Rich Plasma (PRP) Market is segmented as follows:

  • Global Platelet Rich Plasma (PRP) Market, by Types
    • Pure-Platelet Rich Plasma (P-PRP)
    • Leukocyte-Platelet Rich Plasma (L-PRP)
    • Leukocyte-Platelet Rich Fibrin (L-PRF)
  • Global Platelet Rich Plasma (PRP) Market, by Origin
    • Autologus
    • Homologus
    • Allogenic
  • Global Platelet Rich Plasma (PRP) Market, by Applications
    • Orthopedic Surgery
    • Cosmetic Surgery
    • General Surgery
    • Neurosurgery
    • Other Surgeries (Urological, Cardiothoracic, Periodontal and Oral and Maxillofacial)
  • Global Platelet Rich Plasma (PRP) Market, by Geography
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World (RoW)

Platelet Rich Plasma Market Reports - Table of Contents

1. Preface

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

1.3.1 Sources

1.3.1.1 Secondary Research

1.3.1.2 Primary Research

1.3.2 Assumptions

2. Executive Summary

2.1 Market Snapshot: Global PRP Market (2016 & 2026)

2.2 Global PRP Market, by Types, 2016 (US$ Mn)

2.3 Global PRP Market, by Origin, 2016 (US$ Mn)

2.4 Global PRP Market, by Applications, 2016 (US$ Mn)

2.5 Comparative Analysis: Global PRP Market, By Geography, 2016 & 2026 (Value %)

3. Market Overview: Platelet Rich Plasma Market

3.1 Introduction and Market Definition

3.2 Event Impact Analysis

3.3 Market Dynamics

3.3.1 Market Drivers

3.3.2 Market Restraints

3.3.3 Opportunities

3.4 Porters Five Force Analysis for the Global Platelet Rich Plasma (PRP) Market

3.4.1 Bargaining Power of Suppliers

3.4.2 Bargaining Power of Buyers

3.4.3 Threat of Substitutes

3.4.4 Threat of New Entrants

3.4.5 Competitive Rivalry

3.5 Value Chain Analysis

3.6 Regulatory Scenario

3.7 Market Attractiveness Analysis: Global Platelet Rich Plasma (PRP) Market, by Geography, 2016

3.8 Competitive Landscape

3.8.1 Global PRP Market Share Analysis, by Key Players, 2013 (Value %)

4. Global Platelet-Rich Plasma Market, by Types

4.1 Overview

4.1.1 Global PRP Market Revenue, by Types, 2012 – 2026 (US$ Mn)

4.2 Pure Platelet-Rich Plasma (P-PRP)

4.2.1 Global Pure Platelet-Rich Plasma Market Revenue, 2012 – 2026, (US$ Mn)

4.3 Leukocyte-Rich Platelet-Rich Plasma (L-PRP)

4.3.1 Global Leukocyte-Rich Platelet Rich Plasma Market Revenue, 2012 – 2026, (US$ Mn)

4.4 Pure Platelet-Rich Fibrin (P-PRF)/ Leukocyte-Rich Platelet-Rich Fibrin (L-PRF)

4.4.1 Global Leukocyte-Rich Platelet Rich Fibrin Market Revenue, 2012 – 2026, (US$ Mn)

5. Global Platelet-Rich Plasma Market, by Origin

5.1 Overview

5.1.1 Global PRP Market Revenue, by Origin, 2012 – 2026 (US$ Mn)

5.2 Autologus Platelet-Rich Plasma

5.2.1 Global Autologus Platelet-Rich Plasma Market Revenue, 2012 – 2026, (US$ Mn)

5.3 Allogenic Platelet-Rich Plasma

5.3.1 Global Allogenic Platelet-Rich Plasma Market Revenue, 2012 – 2026, (US$ Mn)

5.4 Homologus Platelet-Rich Plasma

5.4.1 Global Homologus Platelet-Rich Plasma Market Revenue, 2012 – 2026, (US$ Mn)

6. Global Platelet-Rich Plasma Market, by Applications

6.1 Overview

6.1.1 Global PRP Market Revenue, by Applications, 2012 – 2026 (US$ Mn)

6.2 Orthopedic Surgery

6.2.1 Global Orthopedic Surgery Market Revenue, 2012 – 2026, (US$ Mn)

6.3 Cosmetic Surgery

6.3.1 Global Cosmetic Surgery Market Revenue, 2012 – 2026, (US$ Mn)

6.4 General Surgery

6.4.1 Global General Surgery Market Revenue, 2012 – 2026, (US$ Mn)

6.5 Neurosurgery

6.5.1 Global Neurosurgery Market Revenue, 2012 – 2026, (US$ Mn)

6.6 Other Surgeries (Urology, Cardiothoracic, Oral & Maxillofacial and Periodontal)

6.6.1 Global Other Surgeries Market Revenue, 2012 – 2026, (US$ Mn)

7. Global Platelet Rich Plasma Market, by Geography

7.1 Overview

7.1.1 Global PRP Market Revenue, by Geography, 2012 – 2026 (US$ Mn)

7.2 North America

7.2.1 North America PRP Market, by Types, 2012 – 2026 (US$ Mn)

7.2.2 North America PRP Market, by Origin, 2012 – 2026 (US$ Mn)

7.2.3 North America PRP Market, by Applications, 2012 – 2026 (US$ Mn)

7.3 Europe

7.3.1 Europe PRP Market, by Types, 2012 – 2026 (US$ Mn)

7.3.2 Europe PRP Market, by Origin, 2012 – 2026 (US$ Mn)

7.3.3 Europe PRP Market, by Applications, 2012 – 2026 (US$ Mn)

7.4 Asia-Pacific

7.4.1 Asia-Pacific PRP Market, by Types, 2012 – 2026 (US$ Mn)

7.4.2 Asia-Pacific PRP Market, by Origin, 2012 – 2026 (US$ Mn)

7.4.3 Asia-Pacific PRP Market, by Applications, 2012 – 2026 (US$ Mn)

7.5 Rest of the World (RoW)

7.5.1 RoW PRP Market, by Types, 2012 – 2026 (US$ Mn)

7.5.2 RoW PRP Market, by Origin, 2012 – 2026 (US$ Mn)

7.5.3 RoW PRP Market, by Applications, 2012 – 2026 (US$ Mn)

8. Recommendations

8.1 Investment in emerging markets would open new avenues to accentuate market share

8.2 Development of new PRP devices and discovery of new application areas would fuel market growth

8.3 Commercialization and promotion of technologically advanced PRP devices to boost market growth

9. Company Profiles

9.1 AdiStem Ltd.

9.1.1 Company Overview

9.1.2 Financial Overview

9.1.3 Product Portfolio

9.1.4 Business Strategies

9.1.5 Recent Developments

9.2 Arteriocyte Medical Systems, Inc.

9.2.1 Company Overview

9.2.2 Financial Overview

9.2.3 Product Portfolio

9.2.4 Business Strategies

9.2.5 Recent Developments

9.3 Arthrex, Inc.

9.3.1 Company Overview

9.3.2 Financial Overview

9.3.3 Product Portfolio

9.3.4 Business Strategies

9.3.5 Recent Developments

9.4 Biomet, Inc.

9.4.1 Company Overview

9.4.2 Financial Overview

9.4.3 Product Portfolio

9.4.4 Business Strategies

9.4.5 Recent Developments

9.5 Cesca Therapeutics, Inc.

9.5.1 Company Overview

9.5.2 Financial Overview

9.5.3 Product Portfolio

9.5.4 Business Strategies

9.5.5 Recent Developments

9.6 DePuy Synthes, Inc. (DePuy Mitek Sports Medicine)

9.6.1 Company Overview

9.6.2 Financial Overview

9.6.3 Product Portfolio

9.6.4 Business Strategies

9.6.5 Recent Developments

9.7 Dr. PRP America LLC

9.7.1 Company Overview

9.7.2 Financial Overview

9.7.3 Product Portfolio

9.7.4 Business Strategies

9.7.5 Recent Developments

9.8 EmCyte Corporation

9.8.1 Company Overview

9.8.2 Financial Overview

9.8.3 Product Portfolio

9.8.4 Business Strategies

9.8.5 Recent Developments

9.9 Exactech, Inc.

9.9.1 Company Overview

9.9.2 Financial Overview

9.9.3 Product Portfolio

9.9.4 Business Strategies

9.9.5 Recent Developments

9.10 Harvest Technologies Corp.

9.10.1 Company Overview

9.10.2 Financial Overview

9.10.3 Product Portfolio

9.10.4 Business Strategies

9.10.5 Recent Developments

9.11 Nuo Therapeutics, Inc. (Cytomedix, Inc.)

9.11.1 Company Overview

9.11.2 Financial Overview

9.11.3 Product Portfolio

9.11.4 Business Strategies

9.11.5 Recent Developments

9.12 Regen Lab SA

9.12.1 Company Overview

9.12.2 Financial Overview

9.12.3 Product Portfolio

9.12.4 Business Strategies

9.12.5 Recent Developments

9.13 Stryker Corporation

9.13.1 Company Overview

9.13.2 Financial Overview

9.13.3 Product Portfolio

9.13.4 Business Strategies

9.13.5 Recent Developments

Platelet Rich Plasma Market Reports - List of Tables

TABLE 1 Market Snapshot: Global PRP Market (2016 & 2026) 

TABLE 2 Global PRP Market Revenue, by Types, 2012 – 2026 (US$ Mn) 

TABLE 3 Global PRP Market Revenue, by Origin, 2012 – 2026 (US$ Mn) 

TABLE 4 Global PRP Market Revenue, by Applications, 2012 – 2026 (US$ Mn) 

TABLE 5 Global PRP Market Revenue, by Geography, 2012 – 2026 (US$ Mn) 

TABLE 6 North America PRP Market Revenue, by Country, 2012 – 2026 (US$ Mn) 

TABLE 7 North America PRP Market Revenue, by Types, 2012 – 2026 (US$ Mn) 

TABLE 8 North America PRP Market Revenue, by Origin, 2012 – 2026 (US$ Mn) 

TABLE 9 North America PRP Market Revenue, by Application, 2012 – 2026 (US$ Mn) 

TABLE 10 U.S. PRP Market Revenue, by Types, 2012 – 2026 (US$ Mn) 

TABLE 11 U.S. PRP Market Revenue, by Origin, 2012 – 2026 (US$ Mn) 

TABLE 12 U.S. PRP Market Revenue, by Application, 2012 – 2026 (US$ Mn) 

TABLE 13 Canada PRP Market Revenue, by Types, 2012 – 2026 (US$ Mn) 

TABLE 14 Canada PRP Market Revenue, by Origin, 2012 – 2026 (US$ Mn) 

TABLE 15 Canada PRP Market Revenue, by Application, 2012 – 2026 (US$ Mn) 

TABLE 16 Europe PRP Market Revenue, by Types, 2012 – 2026 (US$ Mn) 

TABLE 17 Europe PRP Market Revenue, by Origin, 2012 – 2026 (US$ Mn) 

TABLE 18 Europe PRP Market Revenue, by Application, 2012 – 2026 (US$ Mn) 

TABLE 19 Asia-Pacific PRP Market Revenue, by Types, 2012 – 2026 (US$ Mn) 

TABLE 20 Asia-Pacific PRP Market Revenue, by Origin, 2012 – 2026 (US$ Mn) 

TABLE 21 Asia-Pacific PRP Market Revenue, by Application, 2012 – 2026 (US$ Mn) 

TABLE 22 RoW PRP Market Revenue, by Types, 2012 – 2026 (US$ Mn) 

TABLE 23 RoW PRP Market Revenue, by Origin, 2012 – 2026 (US$ Mn) 

TABLE 24 RoW PRP Market Revenue, by Application, 2012 – 2026 (US$ Mn) 

Platelet Rich Plasma Market Reports - List of Figures

FIG. 1 Market Segmentation : Platelet Rich Plasma (PRP) Market 

FIG. 2 Global PRP Market, by Types, 2016 (US$ Mn) 

FIG. 3 Global PRP Market, by Origin, 2016 (US$ Mn) 

FIG. 4 Global PRP Market, by Applications, 2016 (US$ Mn) 

FIG. 5 Comparative Analysis: Global PRP Market, by Geography, 2016 & 2026 (Value %) 

FIG. 6 Preparation Procedure: Platelet Rich Plasma Market 

FIG. 7 Porter’s Five Forces Analysis: Global Platelet Rich Plasma (PRP) Market

FIG. 8 Value Chain Analysis for Platelet Rich Plasma Market

FIG. 9 Market Attractiveness Analysis: Global Platelet Rich Plasma Market, by Geography, 2016

FIG. 10 Global PRP Market Share Analysis, by Key Players, 2013 ( Value %)

FIG. 11 North America PRP Market Share Analysis, by Key Players, 2013 (Value %)

FIG. 12 U.S. PRP Market Share Analysis, by Key Players, 2013 (Value %)

FIG. 13 Canada PRP Market Share Analysis, by Key Players, 2013 (Value %)

FIG. 14 Global Pure Platelet-Rich Plasma Market Revenue, 2012 - 2026 (US$ Mn) 

FIG. 15 Global Leukocyte- Rich Platelet Rich Plasma Market Revenue, 2012 - 2026 (US$ Mn) 

FIG. 16 Global Leukocyte- Rich Platelet Rich Fibrin Market Revenue, 2012 - 2026 (US$ Mn) 

FIG. 17 Global Autologus Platelet-Rich Plasma Market Revenue, 2012 - 2026 (US$ Mn) 

FIG. 18 Global Allogenic Platelet-Rich Plasma Market Revenue, 2012 - 2026 (US$ Mn) 

FIG. 19 Global Homologus Market Revenue, 2012 - 2026 (US$ Mn) 

FIG. 20 Global Orthopedic Surgery Market Revenue, 2012 - 2026 (US$ Mn) 

FIG. 21 Global Cosmetic Surgery Market Revenue, 2012 - 2026 (US$ Mn) 

FIG. 22 Global General Surgery Market Revenue, 2012 - 2026 (US$ Mn) 

FIG. 23 Global Neurosurgery Market Revenue, 2012 - 2026 (US$ Mn) 

FIG. 24 Global Other Surgeries Market Revenue, 2012 - 2026 (US$ Mn) 

FIG. 25 Biomet, Inc.: Annual Revenue, 2011 – 2013 (US$ Mn) 

FIG. 26 Cesca Therapeutics, Inc.: Annual Revenue, 2011 – 2013 (US$ Mn) 

FIG. 27 Exactech, Inc.: Annual Revenue, 2011 – 2013 (US$ Mn) 

FIG. 28 Nuo Therapeutics, Inc. (Cytomedix, Inc.): Annual Revenue, 2011 – 2013 (US$ Mn) 

FIG. 29 Stryker Corporation: Annual Revenue, 2011 – 2013 (US$ Mn)